1. Home
  2. ATHA vs MXC Comparison

ATHA vs MXC Comparison

Compare ATHA & MXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATHA
  • MXC
  • Stock Information
  • Founded
  • ATHA 2011
  • MXC 1972
  • Country
  • ATHA United States
  • MXC United States
  • Employees
  • ATHA N/A
  • MXC N/A
  • Industry
  • ATHA Medicinal Chemicals and Botanical Products
  • MXC Oil & Gas Production
  • Sector
  • ATHA Health Care
  • MXC Energy
  • Exchange
  • ATHA Nasdaq
  • MXC Nasdaq
  • Market Cap
  • ATHA 14.8M
  • MXC 17.6M
  • IPO Year
  • ATHA 2020
  • MXC N/A
  • Fundamental
  • Price
  • ATHA $0.36
  • MXC $8.35
  • Analyst Decision
  • ATHA Hold
  • MXC
  • Analyst Count
  • ATHA 3
  • MXC 0
  • Target Price
  • ATHA $0.50
  • MXC N/A
  • AVG Volume (30 Days)
  • ATHA 159.8K
  • MXC 3.0K
  • Earning Date
  • ATHA 11-06-2025
  • MXC 11-06-2025
  • Dividend Yield
  • ATHA N/A
  • MXC 1.20%
  • EPS Growth
  • ATHA N/A
  • MXC 44.21
  • EPS
  • ATHA N/A
  • MXC 0.79
  • Revenue
  • ATHA N/A
  • MXC $7,444,407.00
  • Revenue This Year
  • ATHA N/A
  • MXC N/A
  • Revenue Next Year
  • ATHA N/A
  • MXC N/A
  • P/E Ratio
  • ATHA N/A
  • MXC $10.54
  • Revenue Growth
  • ATHA N/A
  • MXC 13.06
  • 52 Week Low
  • ATHA $0.22
  • MXC $5.89
  • 52 Week High
  • ATHA $0.83
  • MXC $16.00
  • Technical
  • Relative Strength Index (RSI)
  • ATHA 36.59
  • MXC 49.91
  • Support Level
  • ATHA $0.35
  • MXC $8.30
  • Resistance Level
  • ATHA $0.40
  • MXC $8.82
  • Average True Range (ATR)
  • ATHA 0.02
  • MXC 0.26
  • MACD
  • ATHA -0.00
  • MXC 0.03
  • Stochastic Oscillator
  • ATHA 11.86
  • MXC 41.24

About ATHA Athira Pharma Inc.

Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) is a small molecule drug candidate designed to enhance the activity of the neurotrophic hepatocyte growth factor (HGF) system; ATH-1020 a novel, orally available, next-generation small molecule drug candidate designed to positively modulate the neurotrophic HGF system; ATH-1105 is a novel, orally available, next-generation, small molecule drug candidate designed to positively modulate the neurotrophic HGF system.

About MXC Mexco Energy Corporation

Mexco Energy Corporation is an independent oil and gas company. It is engaged in the acquisition, exploration, development, and production of natural gas and crude oil properties located in the United States. The company carried out its operation in the Permian Basin of West Texas. It is focusing on two primary areas, the Delaware Basin located in the Western portion of the Permian Basin including Lea and Eddy Counties, New Mexico and Loving County, Texas, and the Midland Basin located in the Eastern portion of the Permian Basin including Reagan, Upton, Midland, Martin, Howard, and Glasscock Counties, Texas. The company generates revenue from Oil sales, Natural gas sales, oil and gas royalty interests.

Share on Social Networks: